MIT Technology Review discovered that the stealth startup’s founder John Schloendorn also pitched a startling, medically ...

Announced partnership with Australian CRO to accelerate initiation of CLD-401 clinical trialThe Company has received feedback from the FDA ...

Crispr Therapeutics AG looks set for 2026 revenue inflection as Casgevy ramps; strong efficacy, undervalued shares, robust ...

I have been curious about how my colleagues across the nation are teaching and designing courses in the wake of of more ...

NCERT-based questions dominate while pedigree analysis and application-based sections test deeper understanding; overall ...

The CBSE Class 12 Biology exam was largely balanced and easy to attempt, with direct MCQs and familiar question patterns ...

In a new study of viral abundance over a short time frame in the Sargasso Sea, researchers found that almost all viruses with ...

Today's nearly $70 billion U.S. biofuels economy is powered by two technology toolboxes. Biochemical technologies—used to produce around 17 billion gallons of ethanol annually—leverage microorganisms ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today reported its business update and ...

The Long US Healthcare and Long European Healthcare Equities tilts contributed the most while there were no material tilt ...

Lacutamab TELLOMAK-3 confirmatory Phase 3 trial in cutaneous T-cell lymphoma (CTCL) is planned for initiation in H2 2026, subject to non-dilutive financing options currently under negotiation, includi ...

The World Technology Congress (WTC) has announced that Vincent Y.C. Tsai will participate in its 5th Session at Lake Como from April 22–24, 2026, contributing a key perspective from Taiwan, a global ...